Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
4.135
-0.095 (-2.25%)
May 21, 2025, 3:08 PM - Market open
Y-mAbs Therapeutics Market Cap
Y-mAbs Therapeutics has a market cap or net worth of $187.25 million as of May 21, 2025. Its market cap has decreased by -75.11% in one year.
Market Cap
187.25M
Enterprise Value
129.35M
1-Year Change
-75.11%
Ranking
Category
Stock Price
$4.14
Market Cap Chart
Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $187.25M, a decrease of -76.50%. That is a compound annual growth rate of -19.53%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |